We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Cullinan Oncology
CGEM
$1.14B
| $553K | ﹤0.01% |
43,123
+11,078
| +35% | +$126K |
|
2452
Evolus
EOLS
$501M
| $553K | ﹤0.01% |
47,653
+13,396
| +39% | +$158K |
|
2453
Inovio Pharmaceuticals
INO
$69M
| $553K | ﹤0.01% |
26,633
+2,721
| +11% | +$76.7K |
|
|
FIRY
2454
Firy Inc
FIRY
$163M
| $552K | ﹤0.01% |
22,275
+8,707
| +64% | +$340K |
|
|
CVT
2455
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $552K | ﹤0.01% |
+119,391
| New | +$696K |
|
2456
Treace Medical Concepts
TMCI
$309M
| $550K | ﹤0.01% |
38,379
+9,640
| +34% | +$162K |
|
|
KZR
2457
DELISTED
Kezar Life Sciences
KZR
| $549K | ﹤0.01% |
6,637
+1,985
| +43% | +$175K |
|
2458
IDT Corp
IDT
$1.62B
| $548K | ﹤0.01% |
21,800
-3,662
| -14% | -$101K |
|
2459
West Bancorporation
WTBA
$485M
| $547K | ﹤0.01% |
22,478
+1,486
| +7% | +$37K |
|
|
BTRS
2460
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $547K | ﹤0.01% |
109,754
+38,164
| +53% | +$219K |
|
|
PETQ
2461
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $546K | ﹤0.01% |
32,495
+5,810
| +22% | +$107K |
|
2462
Luxfer Holdings
LXFR
$458M
| $543K | ﹤0.01% |
35,910
+5,643
| +19% | +$91.3K |
|
2463
uniQure
QURE
$3.22B
| $543K | ﹤0.01% |
29,153
-707
| -2% | -$11.2K |
|
|
TPIC
2464
DELISTED
TPI Composites
TPIC
| $542K | ﹤0.01% |
43,340
+3,169
| +8% | +$41.5K |
|
|
KNTE
2465
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $542K | ﹤0.01% |
42,957
+10,878
| +34% | +$101K |
|
2466
Archer Aviation
ACHR
$4.26B
| $539K | ﹤0.01% |
+175,148
| New | +$705K |
|
|
INST
2467
DELISTED
Instructure Holdings, Inc.
INST
| $538K | ﹤0.01% |
23,708
+9,740
| +70% | +$184K |
|
2468
Mid Penn Bancorp
MPB
$952M
| $537K | ﹤0.01% |
19,927
+5,543
| +39% | +$148K |
|
2469
Senseonics Holdings Inc
SENS
$366M
| $537K | ﹤0.01% |
26,060
+4,081
| +19% | +$106K |
|
|
SFIX
2470
Stitch Fix
SFIX
$560M
| $536K | ﹤0.01% |
108,489
+21,657
| +25% | +$181K |
|
|
ME
2471
DELISTED
23andMe Holding Co
ME
| $533K | ﹤0.01% |
+10,753
| New | +$623K |
|
|
TPC
2472
Tutor Perini Cor
TPC
$5.21B
| $531K | ﹤0.01% |
60,471
+4,504
| +8% | +$43.5K |
|
|
REVG
2473
DELISTED
REV Group
REVG
| $529K | ﹤0.01% |
48,631
+6,431
| +15% | +$76.2K |
|
2474
Alto Ingredients
ALTO
$340M
| $527K | ﹤0.01% |
142,128
+29,547
| +26% | +$154K |
|
2475
OneSpaWorld
OSW
$2.66B
| $527K | ﹤0.01% |
73,566
+15,558
| +27% | +$144K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.